Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Kidney Protective Jacket to keep donated kidneys cool during transplant

Official title: The Effect of Intraoperative Thermal Kidney Insulation on Current Kidney Transplantation Surgical Practices

Run by iiShield · NCT07348458 · Data updated 2026-11-12

This project will test a device called the Kidney Protective Jacket to help keep donated kidneys cooler during implantation for adults having their first or second kidney transplant.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsoriiShield
Industry-sponsored
Locations1 site (Westmead, New South Wales)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedJune 30, 2026
Study endsDecember 31, 2026
Registry record updatedMarch 25, 2026
Trial IDNCT07348458 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older receiving their first or second kidney transplant from a suitable deceased or living donor who can provide informed consent are the intended participants.

Probably not a fit

Patients receiving pediatric donor kidneys (donors under 16), those with a known silicone allergy, and recipients beyond a second transplant are excluded and therefore unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a safety-focused interventional study using the Kidney Protective Jacket (KPJ) during kidney transplantation to limit re-warming of the organ during the anastomosis phase. The device is applied to donated kidneys removed from cold storage and is intended to reduce second warm ischemic time-related temperature rise that contributes to ischemia-reperfusion injury. The study will include suitable deceased and living donor kidneys transplanted into consenting adults (age ≥18) undergoing their first or second transplant, with exclusions for pediatric donor kidneys and silicone allergy. Investigators aim to use the device across a range of anatomical and procedural scenarios (single/multiple renal vessels, varying kidney sizes and recipient body sizes) to document safety in typical clinical practice.

Why it matters

Potential benefit: If safe and effective at limiting kidney re-warming, the device could reduce ischemia-reperfusion injury and improve early graft function and outcomes after transplant.

How similar studies have gone: Previous research has shown that keeping kidneys cooler during implantation can reduce temperature rise and related injury, but the Kidney Protective Jacket itself is a novel device with limited prior clinical data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All deceased and living donor kidneys that are deemed suitable for transplantation
* All suitable recipients who are 18 years or greater, and undergoing their first or second kidney transplant
* All recipients must be able to provide full informed consent

Exclusion Criteria:

* Paediatric donor kidneys (kidneys from donors \< 16 years in age)
* Patients with a known allergy or hypersensitivity to silicone

Where it's running

  • Westmead Hospital
    Westmead, New South Wales, Australia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.